The construction of human chorionic gonadotropin β-subunit glycoprotein (hCGβ) DNA vaccine and its preliminary antitumor study

Progress in Biochemistry and Biophysics

Volumn 30, Issue 1, 2003, Pages 60-66

  Chen, Yun ^a   Shi, Shu Qun ^a   Yang, Ying ^a   Peng, Jing Pian ^a  

^a INSTITUTE OF ZOOLOGY   (China)

Author keywords

Antitumor effects; Construction; DNA vaccine; Expression; HCG ; Immunization; PCR3.1 hCG

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; DNA VACCINE; PLASMID DNA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER; GENE INSERTION; GENE ISOLATION; HELA CELL; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOTHERAPY; IN VITRO STUDY; INOCULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR;

EUKARYOTA;

EID: 0037309028     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gawronska B, Leuschner C, Enright F M, et al. Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo. Gynecol Oncol, 2002, 85 (1): 45-52
2. Lundin M, Nordling S, Carpelan-Holmstrom M, et al. A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer. Anticancer Res, 2000, 20 (6D): 4949-4951
3. Marcillac I, Cottu P, Theodore C, et al. Free hCG-beta subunit as tumour marker in urothelial cancer. Lancet, 1993, 341 (8856): 1354-1355
4. Okamoto T, Niu R, Matsuo K, et al. Human chorionic gonadotropin beta-core fragment is directly produced by cancer cells. Life Sci, 2001, 68 (8): 861-872
5. Mungan T, Kuscu E, Ugur M, et al. Screening of persistent trophoblastic disease with various serum markers. Eur J Gynaecol Oncol, 1998, 19 (5): 495-497
6. Gregory J J, Finlay J L. Alpha-fetoprotein and beta-human chorionic gonadotropin: their clinical significance as tumour markers. Drugs, 1999, 57 (4): 463-467
7. Hoshi S, Suzuki K, Ishidoya S, et al. Significance of simultaneous determination of serum human chorionic gonadotropin (hCG) and hCG-beta in testicular tumor patients. Int J Uroi, 2000, 7 (6): 218-223
8. Crawford R A, Iles R K, Carter P G, et al. The prognostic significance of beta human chorionic gonadotrophin and its metabolites in women with cervical carcinoma. J Clin Pathol, 1998, 51 (9): 685-688
9. Triozzi P L, Stevens V C. Human chorionic gonadotropin as a target for cancer vaccines. Oncol Rep, 1999, 6 (1): 7-17
10. Triozzi P L, Stevens V C, Aldrich W, et al. Effects of a beta-human chorionic gonadotropin subunit immunogen administered in aqueous solution with a novel nonionic block copolymer adjuvant in patients with advanced cancer. Clin Cancer Res, 1997, 3 (12Pt1): 2355-2362
11. Gillott D J, Iles R K, Chard T. The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br J Cancer, 1996, 73 (3): 323-326
12. Geissler M, Wands G, Gesien A, et al. Genetic immunization with the free human chorionic gonadotropin beta subunit elicits cytotoxic T lymphocyte responses and protects against tumor formation in mice. Lab Invest, 1997, 76 (6): 859-871
13. Gillott D J, Iles R K, Chard T. The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br J Cancer, 1996, 73 (3): 323-326
14. Talwar G P. Vaccines and passive immunological approaches for the control of fertility and hormone-dependent cancers. Immunol Rev, 1999, 171: 173-192
15. Dangles V, Halberstam I, Scardino A, et al. Tumor-associated antigen human chorionic gonadotropin beta contains numerous antigenic determinants recognized by in vitro-induced CD8+ and CD4+ T lymphocytes. Cancer Immunol Immunother, 2002, 50 (12): 673-681
16. Hasan U A, Abai A M, Harper D R, et al. Nucleic acid immunization: concepts and techniques associated with third generation vaccines. J Immunol Meth, 1999, 229 (1-2): 1-22
17. Schultz J, Dollenmaier G, Moiling K. Update on antiviral DNA vaccine research (1998-2000). Intervirology, 2000, 43 (4-6): 197-217
18. Chen Y, Liu Z, Peng J P. Identification of beta subunit of the rhesus monkey chorionic gonadotropin (rmCG). Molecular and Cellular Biochemistry, 2001, 218 (1-2): 157-163
19. Kerr P J, Jackson R J, Robinson A J, et al. Infertility in female rabbits (Oryctolagus cuniculus) alloimmunized with the rabbit zona pellucida protein ZPB either as a purified recombinant protein or expressed by recombinant myxoma virus. Biol Reprod, 1999, 61: 606-613
20. Bidart J M, Troalen F, Bohuon C J, et al. Immunochemical mapping of a specific domain on human chorionic gonadotropin using anti-protein and anti-peptide monoclonal antibodies. J Biol Chem, 1987, 262 (32): 15483-15489
21. Dirnhofer S, Madersbacher S, Bidart J M, et al. The molecular basis for epitopes on the free beta-subunit of human chorionic gonadotrophin (hCG), its carboxyl-terminal peptide and the hCG beta-core fragment. J Endocrinol, 1994, 141 (1): 153-162
22. Stephan D, Klieber R, de Leeuw R, et al. Functional and immunological relevance of the COOH-terminal extension of human chorionic gonadotropin beta: implications for the WHO birth control vaccine. FASEB Journal, 1993, 7: 1381-1385
23. Doe B, Selby M, Barnett S, et al. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrowderived cells. Proc Natl Acad Sci USA, 1996, 93 (16): 8578-8583
24. Corr M, Lee J D, Carsonm D A, et al. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med, 1996, 184: 1555-1560
25. Thomas T, Jonathan A, Walter J S, et al. The immunology of DNA vaccines. In: Lowrie D B, Whalen R G. eds. Methods in Medicine, Totowa NJ: Humana Press Inc, 1999. 37-64
26. Kalantarov G, Acevedo H F. Demonstration of dose dependent cytotoxic activity in cancer cells by specific human chorionic gonadotropin monoclonal antibodies. Cancer, 1998, 83 (4): 783-787